Trial intelligence / Profile preview

Oral vs Intravenous Tranexamic Acid in Lumbar Spine Surgery

NCT03037515Phase 4Completed

Sponsor
Henry Ford Health
Start
Feb 2017
Primary completion
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tranexamic acid in Bleeding, sponsored by Henry Ford Health. Started Feb 2017; status: completed.

02

Drugs

tranexamic acid
03

Conditions

Bleeding

Beyond the preview

Go deeper on NCT03037515.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03037515.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call